Abbott India has informed regarding resignation of Ashok Saini as Commercial Director-GenNext, Vaccines and Neurolife of the Company, effective close of business hours of October 16, 2024, for personal reasons. Further to the above communication and pursuant to Regulation 30 read with Clause 7C of Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it enclosed resignation letter of Ashok Saini.
The above information is a part of company’s filings submitted to BSE.
